TY - JOUR
T1 - Accuracy of faecal calprotectin and neutrophil gelatinase B-associated lipocalin in evaluating subclinical inflammation in ulcerative colitis-the ACERTIVE study
AU - on behalf of the Portuguese IBD Study Group
AU - Magro, Fernando
AU - Lopes, Susana
AU - Coelho, Rosa
AU - Cotter, José
AU - de Castro, Francisca Dias
AU - de Sousa, Helena Tavares
AU - Salgado, Marta
AU - Andrade, Patrícia
AU - Vieira, Ana Isabel
AU - Figueiredo, Pedro
AU - Caldeira, Paulo
AU - Sousa, A.
AU - Duarte, Maria A.
AU - Ávila, Filipa
AU - Silva, João
AU - Moleiro, Joana
AU - Mendes, Sofia
AU - Giestas, Sílvia
AU - Ministro, Paula
AU - Sousa, Paula
AU - Gonçalves, Raquel
AU - Gonçalves, Bruno
AU - Oliveira, Ana
AU - Chagas, Cristina
AU - Torres, Joana
AU - Dias, Cláudia Camila
AU - Lopes, Joanne
AU - Borralho, Paula
AU - Afonso, Joana
AU - Geboes, Karel
AU - Carneiro, Fátima
N1 - Publisher Copyright:
© 2016 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Background and Aims: Mucosal healing and histological remission are different targets for patients with ulcerative colitis, but both rely on an invasive endoscopic procedure. This study aimed to assess faecal calprotectin and neutrophil gelatinase B-associated lipocalin as biomarkers for disease activity in asymptomatic ulcerative colitis patients. Methods: This was a multicentric cross-sectional study including 371 patients, who were classified according to their endoscopic and histological scores. These results were evaluated alongside the faecal levels of both biomarkers. Results: Macroscopic lesions [i.e. endoscopic Mayo score =1] were present in 28% of the patients, and 9% had active disease according to fht Ulcerative Colitis Endoscopic Index of Severity. Moreover, 21% presented with histological inflammation according to the Geboes index, whereas 15% and 5% presented with focal and diffuse basal plasmacytosis, respectively. The faecal levels of calprotectin and neutrophil gelatinase B-associated lipocalin were statistically higher for patients with endoscopic lesions and histological activity. A receiver operating characteristic-based analysis revealed that both biomarkers were able to indicate mucosal healing and histological remission with an acceptable probability, and cut-off levels of 150-250 μg/g for faecal calprotectin and 12 μg/g for neutrophil gelatinase B-associated lipocalin were proposed. Conclusions: Faecal calprotectin and neutrophil gelatinase B-associated lipocalin levels are a valuable addition for assessment of disease activity in asymptomatic ulcerative colitis patients. Biological levels of the analysed biomarkers below the proposed thresholds can rule out the presence of macroscopic and microscopic lesions with a probability of 75-93%. However, caution should be applied whenever interpreting positive results, as these biomarkers present consistently low positive predictive values.
AB - Background and Aims: Mucosal healing and histological remission are different targets for patients with ulcerative colitis, but both rely on an invasive endoscopic procedure. This study aimed to assess faecal calprotectin and neutrophil gelatinase B-associated lipocalin as biomarkers for disease activity in asymptomatic ulcerative colitis patients. Methods: This was a multicentric cross-sectional study including 371 patients, who were classified according to their endoscopic and histological scores. These results were evaluated alongside the faecal levels of both biomarkers. Results: Macroscopic lesions [i.e. endoscopic Mayo score =1] were present in 28% of the patients, and 9% had active disease according to fht Ulcerative Colitis Endoscopic Index of Severity. Moreover, 21% presented with histological inflammation according to the Geboes index, whereas 15% and 5% presented with focal and diffuse basal plasmacytosis, respectively. The faecal levels of calprotectin and neutrophil gelatinase B-associated lipocalin were statistically higher for patients with endoscopic lesions and histological activity. A receiver operating characteristic-based analysis revealed that both biomarkers were able to indicate mucosal healing and histological remission with an acceptable probability, and cut-off levels of 150-250 μg/g for faecal calprotectin and 12 μg/g for neutrophil gelatinase B-associated lipocalin were proposed. Conclusions: Faecal calprotectin and neutrophil gelatinase B-associated lipocalin levels are a valuable addition for assessment of disease activity in asymptomatic ulcerative colitis patients. Biological levels of the analysed biomarkers below the proposed thresholds can rule out the presence of macroscopic and microscopic lesions with a probability of 75-93%. However, caution should be applied whenever interpreting positive results, as these biomarkers present consistently low positive predictive values.
KW - Endoscopic and histological remission
KW - Faecal markers
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=85010891538&partnerID=8YFLogxK
U2 - 10.1093/ecco-jcc/jjw170
DO - 10.1093/ecco-jcc/jjw170
M3 - Article
C2 - 27664275
AN - SCOPUS:85010891538
SN - 1873-9946
VL - 11
SP - 435
EP - 444
JO - Journal of Crohn's and Colitis
JF - Journal of Crohn's and Colitis
IS - 4
ER -